Postoperative nausea and vomiting (PONV) are unpleasant, often underes
timated side effects of anaesthesia and surgery, not devoid of medical
complications, Prevention with antiemetics is only partially effectiv
e. Propofol has been shown recently to possess antiemetic properties i
n several situations. In this prospective, randomized, controlled tria
l, we have compared the antiemetic efficacy of subhypnotic doses of pr
opofol, with Intralipid as placebo, after thyroidectomy. We studied 64
patients of both sexes, aged 22-71 yr, ASA I or II, undergoing thyroi
dectomy. After premedication with a benzodiazepine, balanced anaesthes
ia was produced with isoflurane and nitrous oxide in oxygen, and suppl
ementary analgesia with fentanyl i.v. as required. Postoperative analg
esia was provided with non-opioids, and piritramide 0.25 mg kg(-1) i.m
. on demand. Patients were allocated randomly and blindly to receive a
20-h infusion of either propofol or 10% Intralipid 0.1 ml kg(-1) h(-1
). Intralipid, the excipient of propofol, was chosen as placebo as it
is devoid of antiemetic effects. Sedation scores, respiratory and card
iovascular variables, and incidence of PONV were assessed every 4 h fo
r 24 h. Pulse oximetry and ECG were monitored continuously. Both group
s were comparable in characteristics, surgical and anaesthesia procedu
res, amount of opioids given during and after operation, and total amo
unt of the study drug infused after operation. Occurrence of PONV was
similar before the start (propofol 41%, Intralipid 50%) and after comp
letion (propofol 0.64%, Intralipid 1.6%) of infusion and decreased wit
h time in both groups during the infusion. However, symptoms were redu
ced to nil with propofol but persisted and were more severe with Intra
lipid during infusion (P less than or equal to 0.01). The overall inci
dence of PONV during infusion was 10% (three of 32 patients) in the pr
opofol group and 65% (21 of 32 patients) in the Intralipid group. Card
iovascular and respiratory variables, and Sp(O2) were unaltered, and s
edation decreased similarly with time in both groups. We conclude that
propofol, given at subhypnotic doses, effectively reduced the inciden
ce of PONV without untoward sedative or cardiovascular effects.